Price transparency in healthcare has become more important as consumers increasingly engage in healthcare decision making and are asked to pay more for their care.
Price transparency in healthcare has become more important as consumers increasingly engage in healthcare decision making and are asked to pay more for their care. A new issue brief from America’s Health Insurance Plans (AHIP) takes a look at price transparency efforts, barriers to improved price transparency, and structuring future initiatives.
Making healthcare cost information readily available and usable by consumers is one way health plans and employers are hoping to improve efficiency, clinical effectiveness, and value.
“As a result of the increased recognition of the value of price transparency in informing consumer decision-making and promoting efficient, quality care, health plans, as well as the federal and state governments, have taken steps to increase the availability of price information for health care services and promote its use in consumer decision-making,” according to the AHIP issue brief.
There are really 2 main challenges to implementing price transparency in healthcare, according to the report. One challenge to greater price transparency is that the definition of cost may change depending on who is incurring the cost: the patient, the provider, the insurer, or the employer. The second challenge is simply availability of price information and public interest in using the data provided.
The use of price transparency tools has many benefits. For instance, price transparency for a procedure can reduce that procedure’s market price.
“Price transparency can also reduce claims payments for lab tests, advanced imaging, and clinician office visits, and reduce overall payments made for clinical care,” according to the issue brief.
AHIP also provided key elements that should be used to evolve initiatives and tools to make provider price information available:
“As price transparency initiatives and tools continue to evolve, stakeholders should pursue continued emphasis on the integration of quality information, given existing evidence that cost data, presented with quality data, can influence consumer decision-making and lead to value-based choices,” the brief concludes.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen